Engineers Gate Manager LP

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$311,737

+$173,196 QoQ

Shares Held

83,130

+182.0% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#88

of 178 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. CTMX ranks #111 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$311,737	83,130	+182.0%	Shares	Sole	2026-08-14
2026-03-31	$138,541	29,477	+11.1%	Shares	Sole	2026-05-15
2025-12-31	$113,056	26,539	+161.9%	Shares	Sole	2026-02-17
2022-12-31	$16,216	10,135	-5.2%	Shares	Sole	2023-02-14
2022-09-30	$15,494	10,686	-61.3%	Shares	Sole	2022-11-14
2022-06-30	$50,533	27,614	+0.3%	Shares	Sole	2022-08-15
2022-03-31	$73,489	27,524	-60.1%	Shares	Sole	2022-05-16
2021-12-31	$298,566	68,953	+25.3%	Shares	Sole	2022-02-14
2021-06-30	$348,371	55,035	+86.6%	Shares	Sole	2021-08-16
2021-03-31	$228,035	29,500	+3.8%	Shares	Sole	2021-05-17
2020-09-30	$188,919	28,409	-38.2%	Shares	Sole	2020-11-16
2020-06-30	$383,063	45,986	+248.4%	Shares	Sole	2020-08-17
2020-03-31	$101,244	13,200	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.